Should I buy Xencor Inc (XNCR) stock or is it too late?

Xencor Inc · Health Care · price $24
Logo Xencor IncSee the full Xencor Inc (XNCR) profile
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

Firm-by-firm track record on Xencor Inc

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Wedbush50 %+42.4 %8$30 +28%
RBC Capital33 %+8.7 %9$20 -15%
BMO Capital20 %-35.0 %5$34 +45%
Canaccord Genuity40 %+5.9 %5—
In short — Should you invest in Xencor Inc? Is it too late, still worth it? Analysts are fairly positive (75% buy, median target $30, i.e. +25%), and the most reliable on XNCR targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 75% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
  • Median price target $30, i.e. +25% from the current price ($24).
  • The most reliable firm on XNCR, Wedbush (50% hit rate, 8 scored calls), targets $30 (call made on August 6, 2026, maturing on August 6, 2027) (+28%) in its most recent call, and $26 (call made on July 30, 2026, maturing on July 30, 2027) (+11%) in the one coming due soonest.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 8 ratings, 2 are neutral.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on XNCR

Median target $30 (+25%) · 8 ratings · Buy consensus

Strong Buy113%
Buy563%
Hold225%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Xencor Inc now?

We won't decide for you. The facts: 75% of analysts rate it a buy, median target $30 (+25%), and Wedbush (most reliable on XNCR, 50%) targets $30. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Xencor Inc?

Not according to analysts: the median target ($30) is still +25% above the current price ($24) (most reliable on XNCR: Wedbush, 50%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Xencor Inc still worth investing in?

It depends on the gap between the price ($24) and its estimated value: analysts target $30 on median (+25%), with 75% buys (most reliable on XNCR: Wedbush, 50%). Cross-check with their real reliability on XNCR and the cautions above. Information, not advice.

What's the main risk in buying XNCR?

The consensus is not unanimous: of 8 ratings, 2 are neutral.

→ Go deeper: the full Xencor Inc profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)